These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3620938)

  • 21. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
    Scatton B; Javoy-Agid F; Rouquier L; Dubois B; Agid Y
    Brain Res; 1983 Sep; 275(2):321-8. PubMed ID: 6626985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presynaptic cholinergic dysfunction in patients with dementia.
    Sims NR; Bowen DM; Allen SJ; Smith CC; Neary D; Thomas DJ; Davison AN
    J Neurochem; 1983 Feb; 40(2):503-9. PubMed ID: 6822833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine abnormalities in the brain of scrapie-infected rats.
    Bassant MH; Fage D; Dedek J; Cathala F; Court L; Scatton B
    Brain Res; 1984 Aug; 308(1):182-5. PubMed ID: 6206919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of noradrenaline and serotonin uptake and metabolism in chronic cobalt-induced epilepsy in the rat.
    Trottier S; Claustre Y; Caboche J; Dedek J; Chauvel P; Nassif S; Scatton B
    Brain Res; 1983 Aug; 272(2):255-62. PubMed ID: 6193838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.
    Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM
    Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.
    Mann DM; Yates PO
    Hum Neurobiol; 1986; 5(3):147-58. PubMed ID: 2876973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased activity of surviving locus ceruleus neurons in Alzheimer's disease.
    Hoogendijk WJ; Feenstra MG; Botterblom MH; Gilhuis J; Sommer IE; Kamphorst W; Eikelenboom P; Swaab DF
    Ann Neurol; 1999 Jan; 45(1):82-91. PubMed ID: 9894881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E; Grondin L; Reader TA
    J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic markers and neurochemical correlates of agitation and psychosis in dementia.
    Kirby M; Lawlor BA
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S2-7. PubMed ID: 8561841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.
    Iversen LL; Rossor MN; Reynolds GP; Hills R; Roth M; Mountjoy CQ; Foote SL; Morrison JH; Bloom FE
    Neurosci Lett; 1983 Aug; 39(1):95-100. PubMed ID: 6633940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminergic systems in Alzheimer's disease and Parkinson's disease.
    D'Amato RJ; Zweig RM; Whitehouse PJ; Wenk GL; Singer HS; Mayeux R; Price DL; Snyder SH
    Ann Neurol; 1987 Aug; 22(2):229-36. PubMed ID: 3477996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathology of catecholaminergic innervation of the cerebral cortex in Alzheimer's dementia].
    Berger B; Alvarez C
    Presse Med; 1983 Dec; 12(48):3109-14. PubMed ID: 6228924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.
    Palmer AM; Stratmann GC; Procter AW; Bowen DM
    Ann Neurol; 1988 Jun; 23(6):616-20. PubMed ID: 2457353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls.
    Bridge TP; Kleinman JE; Karoum F; Wyatt RJ
    Neuropsychobiology; 1985; 14(2):57-61. PubMed ID: 4088459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathologic and neurochemical correlates of psychosis in primary dementia.
    Zubenko GS; Moossy J; Martinez AJ; Rao G; Claassen D; Rosen J; Kopp U
    Arch Neurol; 1991 Jun; 48(6):619-24. PubMed ID: 1710105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of norepinephrine, epinephrine, dopamine, serotonin, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindole-3-acetic acid in dog brain.
    Mefford IN; Foutz A; Noyce N; Jurik SM; Handen C; Dement WC; Barchas JD
    Brain Res; 1982 Mar; 236(2):339-49. PubMed ID: 6175382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.